Myelodysplastic syndrome and benzene exposure among petroleum workers: An international pooled analysis

Journal of the National Cancer Institute

Volumn 104, Issue 22, 2012, Pages 1724-1737

  Schnatter, A Robert ^a   Glass, Deborah C ^b   Tang, Gong ^c   Irons, Richard D ^d   Rushton, Lesley ^e  

^a EXXONMOBIL UPSTREAM RESEARCH COMPANY   (United States)

^b MONASH UNIVERSITY   (Australia)

^c UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF COLORADO   (United States)

^e IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BENZENE; PETROLEUM;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; BONE MARROW TUMOR; CASE CONTROL STUDY; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; DOSE RESPONSE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASTIC SYNDROME; MYELOPROLIFERATIVE DISORDER; PRIORITY JOURNAL; RISK FACTOR; WORKER;

ADULT; AUSTRALIA; BENZENE; CANADA; CASE-CONTROL STUDIES; EXTRACTION AND PROCESSING INDUSTRY; GREAT BRITAIN; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; LEUKEMIA, MYELOID, ACUTE; LOGISTIC MODELS; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; MYELOPROLIFERATIVE DISORDERS; OCCUPATIONAL DISEASES; OCCUPATIONAL EXPOSURE; ODDS RATIO; PETROLEUM;

EID: 84870158821     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djs411     Document Type: Article

References (44)

1. Schnatter AR, Kerzic PJ, Zhou Y, et al. Peripheral blood effects in benzeneexposed workers. Chem Biol Interact. 2010;184:174-181.
2. Crump KS. Risk of benzene-induced leukemia: a sensitivity analysis of the pliofilm cohort with additional follow-up and new exposure estimates. J Toxicol Environ Health. 1994;42(2):219-242. (Pubitemid 24197312)
3. Hayes RB, Yin SN, Dosemeci M, et al. Benzene and the dose-related incidence of hematologic neoplasms in China. Chinese Academy of Preventive Medicine-National Cancer Institute Benzene Study Group. J Natl Cancer Inst. 1997;89(14):1065-1071.
4. International Agency for Research on Cancer. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals: Vol. 100F-Evaluation. International Agency for Research on Cancer; 2010. http://monographs.iarc.fr/ ENG/Monographs/vol100F/index.php. Accessed September 20, 2012.
5. Bergsagel DE, Wong O, Bergsagel PL, et al. Benzene and multiple myeloma: appraisal of the scientific evidence. Blood. 1999;94(4):1174-1182. (Pubitemid 29380397)
6. Steinmaus C, Smith AH, Jones RM, Smith MT. Meta-analysis of benzene exposure and non-Hodgkin lymphoma: biases could mask an important association. Occup Environ Med. 2008;65(6):371-378. (Pubitemid 351775796)
7. Kane EV, Newton R. Benzene and the risk of non-Hodgkin lymphoma: a review and meta-analysis of the literature. Cancer Epidemiol. 2010;34(1):7-12.
8. Alexander DD, Wagner ME. Benzene exposure and non-Hodgkin lymphoma: a meta-analysis of epidemiologic studies. J Occup Environ Med. 2010;52(2):169-189.
9. Vlaanderen J, Portengen L, Rothman N, Lan Q, Kromhout H, Vermeulen R. Flexible meta-regression to assess the shape of the benzene-leukemia exposure-response curve. Environ Health Perspect. 2010;118(4):526-532.
10. Schnatter AR, Rosamilia K, Wojcik NC. Review of the literature on benzene exposure and leukemia subtypes. Chem Biol Interact. 2005;153-154:9-21. (Pubitemid 40797792)
11. Schnatter AR, Armstrong TW, Nicolich MJ, et al. Lymphohaematopoietic malignancies and quantitative estimates of exposure to benzene in Canadian petroleum distribution workers. Occup Environ Med. 1996;53(11):773-781. (Pubitemid 26382278)
12. Rushton L, Romaniuk H. A case-control study to investigate the risk of leukaemia associated with exposure to benzene in petroleum marketing and distribution workers in the United Kingdom. Occup Environ Med. 1997;54(3):152-166. (Pubitemid 27100605)
13. Glass DC, Gray CN, Jolley DJ, et al. Leukemia risk associated with lowlevel benzene exposure. Epidemiology. 2003;14(5):569-577. (Pubitemid 40417038)
14. Miller BG, Fransman W, Heederik D, Hurley JF, Kromhout H, Fitzsimons E. A review of the data quality and comparability of case-control studies of low-level exposure to benzene in the petroleum industry. Int Arch Occup Environ Health. 2010;83(1):69-76.
15. Schnatter AR, Katz AM, Nicolich MJ, Thériault G. A retrospective mortality study among Canadian petroleum marketing and distribution workers. Environ Health Perspect. 1993;101(6 suppl):85-99. (Pubitemid 24075481)
16. Rushton L. A 39-year follow-up of the U.K. oil refinery and distribution center studies: results for kidney cancer and leukemia. Environ Health Perspect. 1993;101(6 suppl):77-84. (Pubitemid 24075480)
17. Gun RT, Pratt NL, Griffith EC, Adams GG, Bisby JA, Robinson KL. Update of a prospective study of mortality and cancer incidence in the Australian petroleum industry. Occup Environ Med. 2004;61(2):150-156. (Pubitemid 38141972)
18. Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC Press; 2001.
19. Armstrong TW, Pearlman ED, Schnatter AR, Bowes SM III, Murray N, Nicolich MJ. Retrospective benzene and total hydrocarbon exposure assessment for a petroleum marketing and distribution worker epidemiology study. Am Ind Hyg Assoc J. 1996;57(4):333-343.
20. Lewis SJ, Bell GM, Cordingley N, Pearlman ED, Rushton L. Retrospective estimation of exposure to benzene in a leukaemia case-control study of petroleum marketing and distribution workers in the United Kingdom. Occup Environ Med. 1997;54(3):167-175. (Pubitemid 27092949)
21. Glass DC, Adams GG, Manuell RW, Bisby JA. Retrospective exposure assessment for benzene in the Australian petroleum industry. Ann Occup Hyg. 2000;44(4):301-320. (Pubitemid 30261502)
22. Richardson DB. Temporal variation in the association between benzene and leukemia mortality. Environ Health Perspect. 2008;116(3):370-374. (Pubitemid 351395606)
23. Glass DC, Armstrong TW, Pearlman ED, Verma DK, Schnatter AR, Rushton L. Ensuring comparability of benzene exposure estimates across three nested case-control studies in the petroleum industry in support of a pooled epidemiological analysis. Chem Biol Interact. 2010;184(1-2):101-111.
24. R Foundation for Statistical Computing. A language and environment for statistical computing; 2008. http://www.R-project.org. Accessed May 1, 2010.
25. Insightful Corporation. S-PLUS 8 for Windows User's Guide. Insightful Corporation: Seattle, WA; 2007.
26. SAS Institute Inc. SAS/STAT 9.2 User's Guide. Cary, NC: SAS Institute Inc; 2008.
27. Hahn CN, Chong CE, Carmichael CL, et al. Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia. Nat Genet. 2011;43(10):1012-1017.
28. Bennett JM, Catovsky D, Daniel MT, et al. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol. 1982;51(2):189-199. (Pubitemid 12073508)
29. Harris NL, Jaffe ES, Diebold J, et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory committee meeting, Airlie House, Virginia, November 1997. J Clin Oncol. 1999;17(12):3835-3849.
30. Ma X, Does M, Raza A, Mayne ST. Myelodysplastic syndromes: incidence and survival in the United States. Cancer. 2007;109(8):1536-1542. (Pubitemid 46595689)
31. Jamshidi K, Swaim WR. Bone marrow biopsy with unaltered architecture: a new biopsy device. J Lab Clin Med. 1971;77(2):335-342.
32. Iwanaga M, Hsu WL, Soda M, et al. Risk of myelodysplastic syndromes in people exposed to ionizing radiation: a retrospective cohort study of Nagasaki atomic bomb survivors. J Clin Oncol. 2011;29(4):428-434.
33. Honda Y, Delzell E, Cole P. An updated study of mortality among workers at a petroleum manufacturing plant. J Occup Environ Med. 1995;37(2):194-200.
34. Irons RD, Gross SA, Le A, et al. Integrating WHO 2001-2008 criteria for the diagnosis of myelodysplastic syndrome (MDS): a case-case analysis of benzene exposure. Chem Biol Interact. 2010;184(1-2):30-38.
35. Lv L, Lin G, Gao X, et al. Case-control study of risk factors of myelodysplastic syndromes according to World Health Organization classification in a Chinese population. Am J Hematol. 2011;86(2):163-169.
36. Rinsky RA, Smith AB, Hornung R, et al. Benzene and leukemia. An epidemiologic risk assessment. N Engl J Med. 1987;316(17):1044-1050. (Pubitemid 17047292)
37. ACGIH TLV Documentation Benzene. Cincinnati, OH: American Conference of Governmental Industrial Hygienists; 2001.
38. The WHO European Centre for Environment and Health. WHO Guidelines for Indoor Air Quality: Selected Pollutants. Bonn: World Health Organization; 2010.
39. Wong O, Harris F, Armstrong TW, Hua F. A hospital-based case-control study of non-Hodgkin lymphoid neoplasms in Shanghai: analysis of environmental and occupational risk factors by subtypes of the WHO classification. Chem Biol Interact. 2010;184(1-2):129-146.
40. Leone G, Voso MT, Teofili L, Lübbert M. Inhibitors of DNA methylation in the treatment of hematological malignancies and MDS. Clin Immunol. 2003;109(1):89-102. (Pubitemid 37324746)
41. Kantarjian H, Issa JP, Rosenfeld CS, et al. Decitabine improves patient outcomes in myelodysplastic syndromes: results of a phase III randomized study. Cancer. 2006;106(8):1794-1803.
42. Irons RD, Lv L, Gross SA, et al. Chronic exposure to benzene results in a unique form of dysplasia. Leuk Res. 2005;29(12):1371-1380. (Pubitemid 41562238)
43. Song Y, Du X, Hao F, et al. Immunosuppressive therapy of cyclosporin A for severe benzene-induced haematopoietic disorders and a 6-month follow-up. Chem Biol Interact. 2010;186(1):96-102.
44. Huebner WW, Wojcik NC, Rosamilia K, Jorgensen G, Milano CA. Mortality updates (1970-1997) of two refinery/petrochemical plant cohorts at Baton Rouge, Louisiana, and Baytown, Texas. J Occup Environ Med. 2004;46(12): 1229-1245. (Pubitemid 39644028)